Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFARELIN vs NALBUPHINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFARELIN vs NALBUPHINE: Safety Overview

Metric NAFARELIN NALBUPHINE
Total FAERS Reports 209 702
Deaths Reported 9 78
Death Rate 4.3% 11.1%
Hospitalizations 99 95
Average Patient Age 34.7 yrs 42.1 yrs
% Female Patients 98.6% 63.5%
FDA Approval Date Feb 13, 1990 Approved Prior to Jan 1, 1982
Manufacturer Pfizer Laboratories Div Pfizer Inc Henry Schein, Inc.
Route NASAL INTRAMUSCULAR
Marketing Status Prescription Discontinued